114 related articles for article (PubMed ID: 3095392)
1. Failure of fluosol DA to enhance the ultrasonic image of infarcted myocardium.
Vasey CG; Armstrong WF; West SR; Waller BF; Dillon JC; Feigenbaum H
J Clin Ultrasound; 1986 Oct; 14(8):613-8. PubMed ID: 3095392
[TBL] [Abstract][Full Text] [Related]
2. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs.
Mattrey RF; Andre MP
Am J Cardiol; 1984 Jul; 54(1):206-10. PubMed ID: 6741815
[TBL] [Abstract][Full Text] [Related]
4. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
Kolodgie FD; Dawson AK; Forman MB; Virmani R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 50(2):119-34. PubMed ID: 2868560
[TBL] [Abstract][Full Text] [Related]
5. Effects of perfluorocarbon exchange transfusion on reducing myocardial infarct size in a primate model of ischemia-reperfusion injury: a prospective, randomized study.
Premaratne S; Harada RN; Chun P; Suehiro A; McNamara JJ
Surgery; 1995 Jun; 117(6):670-6. PubMed ID: 7778030
[TBL] [Abstract][Full Text] [Related]
6. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.
Jaffe CC; Wohlgelernter D; Cabin H; Bowman L; Deckelbaum L; Remetz M; Cleman M
Am Heart J; 1988 Jun; 115(6):1156-64. PubMed ID: 2967624
[TBL] [Abstract][Full Text] [Related]
7. [An experimental study on the effect of fluorocarbon perfusion for the preservation of an amputated limb].
Takahashi F
Nihon Seikeigeka Gakkai Zasshi; 1987 Oct; 61(10):1123-34. PubMed ID: 3437177
[TBL] [Abstract][Full Text] [Related]
8. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia.
Kolodgie FD; Dawson AK; Roden DM; Forman MB; Virmani R
Am Heart J; 1986 Dec; 112(6):1192-201. PubMed ID: 3788766
[TBL] [Abstract][Full Text] [Related]
9. [Myocardial contrast echocardiography using artificial blood (Fluosol-DA): a comparison with left ventricular wall motion in the experimental ischemic heart].
Saito H; Ajima H; Suzuki M
J Cardiogr; 1984 Dec; 14(4):677-88. PubMed ID: 6543869
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
11. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
[TBL] [Abstract][Full Text] [Related]
12. Fluorocarbon enhancement of skin flap survival in rats.
Chowdary RP; Berkower AS; Moss ML; Hugo NE
Plast Reconstr Surg; 1987 Jan; 79(1):98-101. PubMed ID: 3797523
[TBL] [Abstract][Full Text] [Related]
13. The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit.
Virmani R; Osmialowski AF; Kolodgie FD; Forman MB
Am J Cardiovasc Pathol; 1990; 3(1):69-80. PubMed ID: 2331363
[TBL] [Abstract][Full Text] [Related]
14. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
Kolodgie FD; Farb A; Carlson GC; Wilson PS; Virmani R
J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
[TBL] [Abstract][Full Text] [Related]
15. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model.
Forman MB; Puett DW; Wilson BH; Vaughn WK; Friesinger GC; Virmani R
J Am Coll Cardiol; 1987 May; 9(5):1082-90. PubMed ID: 3571747
[TBL] [Abstract][Full Text] [Related]
16. Effect of fluocarbon exchange transfusion on myocardial infarction size in dogs.
Nunn GR; Dance G; Peters J; Cohn LH
Am J Cardiol; 1983 Jul; 52(1):203-5. PubMed ID: 6858913
[TBL] [Abstract][Full Text] [Related]
17. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
Cleman M; Jaffee CC; Wohlgelernter D
Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
[TBL] [Abstract][Full Text] [Related]
18. Protection against ischemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or Fluosol.
Robalino BD; Marwick T; Lafont A; Vaska K; Whitlow PL
J Am Coll Cardiol; 1992 Nov; 20(6):1378-84. PubMed ID: 1430688
[TBL] [Abstract][Full Text] [Related]
19. Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty.
Anderson HV; Leimgruber PP; Roubin GS; Nelson DL; Gruentzig AR
Am Heart J; 1985 Oct; 110(4):720-6. PubMed ID: 2931968
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury.
Zikria BA; Subbarao C; Oz MC; Popilkis SJ; Sachdev R; Chauhan P; Freeman HP; King TC
Arch Surg; 1990 Jul; 125(7):930-4. PubMed ID: 1695089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
